'
SCIENTIFIC SCORE
Moderately Effective
Based on 18 Researches
8.4
USERS' SCORE
Good
Based on 20 Reviews
8.8
Supplement Facts
Serving Size: 1 Capsule
Amount Per Serving
%DV
Saccharomyces boulardii(an S. cerevisiae Strain)
250 mg(5 Billion CFU)
MOS Yeast Fraction(Min. 35% Manno-oligosaccharides [MOS]) (S. cerevisiae)
200 mg

Top Medical Research Studies

9
Saccharomyces boulardii shows ulcer benefits
Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-B and Nrf2 Signaling Pathways.
Identified effective ulcer treatment
We explored how the probiotic yeast, Saccharomyces boulardii, impacts ulcerative colitis in mice. Through a careful setup, C57BL/6 mice received the treatment for three weeks and were later exposed to a harmful substance to induce the condition.

The results were promising; we observed that Saccharomyces boulardii significantly improved various symptoms. It helped prevent weight loss, diarrhea, and inflammation while strengthening the intestinal barrier. Furthermore, it demonstrated an ability to counteract oxidative damage effectively.

However, we also noted that while these findings are positive, further research is needed to fully understand the comprehensive benefits of this treatment in humans.
Read More
9
Saccharomyces boulardii reduces ulcer risk
Saccharomyces boulardii alleviates ulcerative colitis carcinogenesis in mice by reducing TNF-α and IL-6 levels and functions and by rebalancing intestinal microbiota.
Highly relevant therapeutic findings
We explored the effects of Saccharomyces boulardii on ulcerative colitis-related cancer in a mouse model.

Mice treated with a combination of azoxymethane and dextran sulfate sodium were given S. boulardii for 12 weeks.

Results showed that S. boulardii significantly lowered tumor load and reduced harmful substances TNF-α and IL-6 in the colon.

Additionally, it positively shifted the gut microbiota composition, suggesting a connection between the treatment and these beneficial outcomes.
Read More
9
QHNLD8L1 shows promise for UC
Anti-Inflammatory, Barrier Maintenance, and Gut Microbiome Modulation Effects of QHNLD8L1 on DSS-Induced Ulcerative Colitis in Mice.
Highly relevant to ulcerative colitis
We explored how the yeast strain QHNLD8L1 may help with ulcerative colitis. In our study, we looked at four different yeast strains and their effects on mice with induced colitis. Notably, QHNLD8L1 showed protective effects, improving body weight and colon length, while reducing inflammation. We also found that it decreased harmful bacteria and boosted beneficial ones, enhancing gut health overall. This indicates that QHNLD8L1 could be a promising approach to manage ulcerative colitis symptoms.
Read More

Most Useful Reviews

9.5
Diet and probiotics combo
Just gentle diet with Saccharomyces boulardii has transformed my life. Having ulcerative colitis for about 8 years, this probiotic, coupled with a careful diet, has brought my symptoms under control. I meticulously adjusted my intake, and my symptoms improved significantly. I believe this product has been essential in protecting my colon from ulceration.
Read More
9.5
Rapid symptom relief
An Amazing Probiotic! After a long round of strong antibiotics for an abscess, my stomach was in turmoil. Despite taking probiotics post-antibiotics, I still felt unwell. However, after just a few days of Saccharomyces Boulardii + MOS, I've noticed substantial improvement. My gut has settled, and I am seeing relief from symptoms associated with my ulcerative colitis.
Read More
9.5
Supports antibiotic treatment
Saccharomyces Boulardii has numerous advantages. It is the only probiotic I can take alongside antibiotics, which is crucial for preserving my gut flora, especially post-COVID. These fungi don’t colonise our intestines but significantly help to maintain a healthy microflora. It is also effective for ulcers caused by pathogenic strains.
Read More

Medical Researches

SCIENTIFIC SCORE
Moderately Effective
Based on 18 Researches
8.4
9.5
Probiotic reduces side effects
Effectiveness of 7-Day and 14-Day Moxifloxacin-Dexlansoprazole Based Triple Therapy and Probiotic Supplement for Helicobacter Pylori Eradication in Thai Patients with Non-Ulcer Dyspepsia: A Double-Blind Randomized Placebo-Controlled Study.
Highly relevant probiotic findings
We looked into how the probiotic Saccharomyces boulardii affects the treatment of Helicobacter pylori in Thai patients. In a double-blind study, participants received either a probiotic or placebo with a moxifloxacin-dexlansoprazole therapy.

While the treatment achieved high eradication rates of H. pylori, we found that the addition of the probiotic significantly reduced side effects like nausea and diarrhea compared to those on placebo. This suggests that Saccharomyces boulardii could enhance patient comfort during an effective antibiotic regimen.
Read More
9
Saccharomyces boulardii aids ulcer treatment
Alleviates Colitis by Regulating FXR-NLRP3 Mediated Macrophage Pyroptosis.
High relevance for colitis management
This study examined how Saccharomyces boulardii supernatant (SbS) impacts ulcerative colitis (UC) by activating the FXR-NLRP3 signaling pathway. We used a murine model to assess the effects of SbS compared to a control group.

Our findings showed that SbS not only activated FXR but also suppressed the NLRP3 inflammasome in colonic tissues. It reduced macrophage pyroptosis, a process linked to inflammation. However, the benefits were reversed by an FXR inhibitor, indicating that FXR’s activation is crucial for SbS's effects.
Read More
9
Targeted Saccharomyces boulardii benefits ulcerative colitis
Targeted delivery of the probiotic Saccharomyces boulardii to the extracellular matrix enhances gut residence time and recovery in murine colitis.
Innovative treatment for bowel diseases
We investigated the impact of a targeted delivery system for Saccharomyces boulardii, a probiotic yeast, aimed at treating ulcerative colitis. In our preclinical studies on female mice, we found that this engineered strain significantly improved gut retention time, increasing it by an extra 24-48 hours.

This enhanced delivery led to a dramatic boost in the concentration of the probiotic in the colon, which resulted in notable improvements in colon health markers. Key indicators like colon length and inflammation scores returned to healthier levels, suggesting promising potential for this targeted treatment strategy in managing inflammatory bowel diseases.
Read More
9
Saccharomyces boulardii shows protective effects
Protective effects of Saccharomyces boulardii CNCM I-745 in an experimental model of NSAID-induced enteropathy.
High relevance for gastrointestinal health
We explored the effects of Saccharomyces boulardii (Sb) in mice with NSAID-induced enteropathy. Through various assessments, including clinical scores and intestinal analyses, we compared four groups: Control, Indomethacin, Sb, and Sb with Indomethacin.

Mice treated with Sb demonstrated significant improvements in their health compared to those only on indomethacin. Sb not only enhanced the intestinal barrier but also positively influenced gut bacteria, reducing inflammation and damage caused by NSAIDs.

Our findings suggest that Sb could serve as a protective agent against NSAID-related intestinal issues.
Read More
9
Saccharomyces boulardii shows ulcer benefits
Ameliorates Dextran Sulfate Sodium-Induced Ulcerative Colitis in Mice by Regulating NF-B and Nrf2 Signaling Pathways.
Identified effective ulcer treatment
We explored how the probiotic yeast, Saccharomyces boulardii, impacts ulcerative colitis in mice. Through a careful setup, C57BL/6 mice received the treatment for three weeks and were later exposed to a harmful substance to induce the condition.

The results were promising; we observed that Saccharomyces boulardii significantly improved various symptoms. It helped prevent weight loss, diarrhea, and inflammation while strengthening the intestinal barrier. Furthermore, it demonstrated an ability to counteract oxidative damage effectively.

However, we also noted that while these findings are positive, further research is needed to fully understand the comprehensive benefits of this treatment in humans.
Read More

User Reviews

USERS' SCORE
Good
Based on 20 Reviews
8.8
9.5
Supports antibiotic treatment
Saccharomyces Boulardii has numerous advantages. It is the only probiotic I can take alongside antibiotics, which is crucial for preserving my gut flora, especially post-COVID. These fungi don’t colonise our intestines but significantly help to maintain a healthy microflora. It is also effective for ulcers caused by pathogenic strains.
Read More
9.5
Alleviates gut inflammation
I find Saccharomyces extremely helpful against acute diarrhoea, especially "travellers' diarrhoea". They inhibit harmful microbes and help with various conditions, including ulcers, Crohn's disease, and food allergies. They significantly enhance gut health and overall immune function.
Read More
9.5
Effective for mouth ulcers
I consistently order this product as it helps restore gut flora post-antibiotics and is indispensable in cases of poisoning. It helped my daughter with her stubborn mouth ulcers within days, making it a staple in our household.
9.5
Improves ulcer recovery
I take this to aid recovery after my stomach ulcer. I've consumed four cans, and my well-being has improved.
9.5
Diet and probiotics combo
Just gentle diet with Saccharomyces boulardii has transformed my life. Having ulcerative colitis for about 8 years, this probiotic, coupled with a careful diet, has brought my symptoms under control. I meticulously adjusted my intake, and my symptoms improved significantly. I believe this product has been essential in protecting my colon from ulceration.
Read More
image